Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Frontiers in Cellular Neuroscience|June 27, 2013
Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathwayDebomoy K Lahiri, Deborah K Sokol, Craig Erickson, et al.Journal of Clinical Immunology|April 25, 2014
Intravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's diseaseScott E Counts, Balmiki Ray, Elliott J Mufson, et al.Translational Psychiatry|February 19, 2020
Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's diseaseBalmiki Ray, Bryan Maloney, Kumar Sambamurti, et al.Translational Psychiatry|March 4, 2020
Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's diseaseBalmiki Ray, Bryan Maloney, Kumar Sambamurti, et al.Current Alzheimer Research|May 1, 2013
Efficacy and toxicity of clioquinol treatment and A-beta42 inoculation in the APP/PSI mouse model of Alzheimer's diseaseYi-Hong Zhang, James Raymick, Sumit Sarkar, et al.American Journal of Medical Genetics. Part A|June 22, 2016
Analysis of peripheral amyloid precursor protein in Angelman SyndromeCraig A Erickson, Logan K Wink, Bayon Baindu, et al.AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|August 26, 2015
Leveraging an Electronic Health Record-Linked Biorepository to Generate a Metformin Pharmacogenomics HypothesisMatthew K Breitenstein, Liewei Wang, Gyorgy Simon, et al.Journal of Neuroscience Research|July 31, 2009
Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic miceGeorge M Alley, Jason A Bailey, Demao Chen, et al.Journal of Psychiatric Research|October 16, 2016
Initial analysis of peripheral lymphocytic extracellular signal related kinase activation in autismCraig A Erickson, Balmiki Ray, Logan K Wink, et al.Psychopharmacology|February 26, 2013
Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndromeCraig A Erickson, Logan K Wink, Balmiki Ray, et al.Pageof 5